Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays

Standard

Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. / Veličković, Vladica M; Rochau, Ursula; Conrads-Frank, Annette; Kee, Frank; Blankenberg, Stefan; Siebert, Uwe.

in: EXPERT REV PHARM OUT, Jahrgang 18, Nr. 6, 12.2018, S. 619-640.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

APA

Vancouver

Bibtex

@article{9d336787ad1841188285aa8a87c8881f,
title = "Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays",
abstract = "INTRODUCTION: Despite the emphasis on the clinical importance of cardiac troponin assays (cTn), there are insufficient cost-effectiveness comparisons of various troponin test protocols for the diagnosis of myocardial infarction (MI). Therefore, the purpose of the review was to identify and systematically assess published economic evaluations using decision-analytic models for diagnostic testing strategies based on cTn and to make recommendations for the development of future models.AREAS COVERED: MEDLINE, Science Direct, Cochrane Database, CRD Database, and gray literature were screened for full economic evaluation studies with relevant clinical outcomes over a defined time horizon addressing a population with suspected MI and comparison of different diagnostic test strategies. Standardized forms for data extraction and evidence tables were used for the summary of study design, methodological framework and data sources. Studies were assessed for quality using the CHEERS and the BMJ checklists.EXPERT COMMENTARY: Although there are 11 identified studies and several well-designed models, there remains a need for decision-analytic models including differential diagnosis for acute MI, different health facility configurations, clinician preferences, and behavioral components, and in the top of the subgroup analyses additional important personalized medicine aspects.",
keywords = "Cost-Benefit Analysis, Decision Support Techniques, Diagnosis, Differential, Diagnostic Tests, Routine/economics, Humans, Models, Economic, Myocardial Infarction/diagnosis, Troponin/analysis",
author = "Veli{\v c}kovi{\'c}, {Vladica M} and Ursula Rochau and Annette Conrads-Frank and Frank Kee and Stefan Blankenberg and Uwe Siebert",
year = "2018",
month = dec,
doi = "10.1080/14737167.2018.1512857",
language = "English",
volume = "18",
pages = "619--640",
journal = "EXPERT REV PHARM OUT",
issn = "1473-7167",
publisher = "EXPERT REVIEWS",
number = "6",

}

RIS

TY - JOUR

T1 - Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays

AU - Veličković, Vladica M

AU - Rochau, Ursula

AU - Conrads-Frank, Annette

AU - Kee, Frank

AU - Blankenberg, Stefan

AU - Siebert, Uwe

PY - 2018/12

Y1 - 2018/12

N2 - INTRODUCTION: Despite the emphasis on the clinical importance of cardiac troponin assays (cTn), there are insufficient cost-effectiveness comparisons of various troponin test protocols for the diagnosis of myocardial infarction (MI). Therefore, the purpose of the review was to identify and systematically assess published economic evaluations using decision-analytic models for diagnostic testing strategies based on cTn and to make recommendations for the development of future models.AREAS COVERED: MEDLINE, Science Direct, Cochrane Database, CRD Database, and gray literature were screened for full economic evaluation studies with relevant clinical outcomes over a defined time horizon addressing a population with suspected MI and comparison of different diagnostic test strategies. Standardized forms for data extraction and evidence tables were used for the summary of study design, methodological framework and data sources. Studies were assessed for quality using the CHEERS and the BMJ checklists.EXPERT COMMENTARY: Although there are 11 identified studies and several well-designed models, there remains a need for decision-analytic models including differential diagnosis for acute MI, different health facility configurations, clinician preferences, and behavioral components, and in the top of the subgroup analyses additional important personalized medicine aspects.

AB - INTRODUCTION: Despite the emphasis on the clinical importance of cardiac troponin assays (cTn), there are insufficient cost-effectiveness comparisons of various troponin test protocols for the diagnosis of myocardial infarction (MI). Therefore, the purpose of the review was to identify and systematically assess published economic evaluations using decision-analytic models for diagnostic testing strategies based on cTn and to make recommendations for the development of future models.AREAS COVERED: MEDLINE, Science Direct, Cochrane Database, CRD Database, and gray literature were screened for full economic evaluation studies with relevant clinical outcomes over a defined time horizon addressing a population with suspected MI and comparison of different diagnostic test strategies. Standardized forms for data extraction and evidence tables were used for the summary of study design, methodological framework and data sources. Studies were assessed for quality using the CHEERS and the BMJ checklists.EXPERT COMMENTARY: Although there are 11 identified studies and several well-designed models, there remains a need for decision-analytic models including differential diagnosis for acute MI, different health facility configurations, clinician preferences, and behavioral components, and in the top of the subgroup analyses additional important personalized medicine aspects.

KW - Cost-Benefit Analysis

KW - Decision Support Techniques

KW - Diagnosis, Differential

KW - Diagnostic Tests, Routine/economics

KW - Humans

KW - Models, Economic

KW - Myocardial Infarction/diagnosis

KW - Troponin/analysis

U2 - 10.1080/14737167.2018.1512857

DO - 10.1080/14737167.2018.1512857

M3 - SCORING: Review article

C2 - 30115001

VL - 18

SP - 619

EP - 640

JO - EXPERT REV PHARM OUT

JF - EXPERT REV PHARM OUT

SN - 1473-7167

IS - 6

ER -